Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is an anticholinergic medication.
## Primary Indications
Presumed indication: Management of excessive salivation (sialorrhea) in pediatric patients.
## Adult Dosing
Adult dosing is not established for this indication.
## Pediatric Dosing
Dosing for pediatric patients with sialorrhea is highly variable and depends on clinical response and tolerability. A common starting point is **0.02 mg/kg/dose** orally three times daily, with a maximum dose of **0.05 mg/kg/dose** orally three times daily, not to exceed **0.2 mg/kg/day**. Doses may be titrated upward based on efficacy and tolerability. Specific dosing protocols may vary by institution.
## Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established in the literature. Use with caution.
## Contraindications
* Known hypersensitivity to walethmade bromide or its components.
* Conditions that could be exacerbated by anticholinergic effects, such as uncontrolled narrow-angle glaucoma, certain gastrointestinal surgeries, or severe ulcerative colitis.
## Adverse Effects
Common anticholinergic adverse effects include: dry mouth, constipation, blurred vision, urinary retention, decreased sweating, drowsiness, and dizziness. Other potential adverse effects include gastrointestinal upset, tachycardia, and cognitive impairment.
## Key Drug Interactions
* **Other Anticholinergic Agents:** Additive anticholinergic effects, increasing the risk of adverse events.
* **CNS Depressants:** May increase sedation.
* **Prokinetics (e.g., metoclopramide, cisapride):** May decrease the efficacy of prokinetic agents.
## Monitoring
* Monitor for therapeutic efficacy (reduction in sialorrhea).
* Monitor for adverse effects, particularly anticholinergic effects.
* Assess for stool frequency and consistency for constipation.
* Monitor fluid intake and output for dehydration or urinary retention.
## Clinical Pearls
* Titrate dose slowly to achieve therapeutic effect while minimizing adverse events.
* Consider a trial period to assess efficacy and tolerability.
* Educate caregivers on potential adverse effects and how to manage them.
* It is crucial to verify the most current prescribing information and institutional protocols before initiating therapy.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace up-to-date official prescribing information or clinical judgment. Always consult the current product monograph and institutional guidelines.
